Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  Samsung Biologics Co.,Ltd.    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
 SummaryChartsNewsRatingsCompanyConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
788000 796000 795000 796000 794000 Last
163860 137717 98277 85041 117646 Volume
-1.99% +1.02% -0.13% +0.13% -0.25% Change
Company
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Notations Surperformance© of Samsung Biologics Co.,Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SAMSUNG BIOLOGICS CO.,LTD.
01/19S.Korean stocks see best day in over a week on Samsung Elec, Hyundai Motor bo..
RE
01/18Samsung Elec's worst fall in 5 mths pulls down KOSPI after group leader's pri..
RE
01/16Samsung's Jay Y. Lee on cusp of stepping out of father's shadow
RE
01/08MARKET CHATTER : Combined Market Cap of Top South Korean Firms Hits $1.6 Trillio..
MT
2020S.Korea shares end at record high on biopharmaceuticals boost
RE
2020MARKET CHATTER : John Rim is the New CEO of Samsung Biologics
MT
2020Samsung Biologics, AstraZeneca Ceases Leukemia Drug Development; JV Likely to..
MT
2020Seoul Stocks Decline as Investors Opt for Profit-Booking at the End of Novemb..
MT
2020MARKET CHATTER : Major Samsung Units' Shares Make Double-Digit Jump After Chairm..
MT
2020MARKET CHATTER : South Korea to Raise Bio-Health Industry Investments to $9 Bill..
MT
2020MARKET CHATTER : Samsung Biologics, Celltrion to Build Fourth Plants at Songdo B..
MT
2020FDA Accepts Biogen, Samsung Bioepis Filing for Lucentis Biosimilar
DJ
2020South Korean Stocks Soar to 33-Month High; Samsung BioLogics, Celltrion Gain;..
MT
2020S.Korea shares rise on hopes of Fed's policy support; rising virus cases weig..
RE
2020Samsung BioLogics says mass producing Eli Lilly's COVID-19 treatment
RE
More news
News in other languages on SAMSUNG BIOLOGICS CO.,LTD.
2020MÄRKTE ASIEN/Gewinnmitnahmen wegen Corona-Sorgen
2020La muerte del presidente de Samsung impulsa a la empresa en bolsa
2020Samsung-Erbe Lee droht wegen Manipulationsvorwürfen die Verhaftung
2020Samsung-Erbe Lee wird wegen umstrittener Firmenfusion vernommen
2019CORÉE DU SUD : mandats d'arrêt contre deux vice-présidents de Samsung Electronic..
More news
Analyst Recommendations on SAMSUNG BIOLOGICS CO.,LTD.
More recommendations
Chart SAMSUNG BIOLOGICS CO.,LTD.
Duration : Period :
Samsung Biologics Co.,Ltd. Technical Analysis Chart | A207940 | KR7207940008 | MarketScreener
Technical analysis trends SAMSUNG BIOLOGICS CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 794 000,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
John Chongbo Rim President, Chief Executive Officer & Director
Tae-Han Kim Chairman
Ho-Yeol Yoon Managing Director & Head-Operations Support
James J. Choi Managing Director & Head-Information Technology
Yong-Ho An Managing Director & Head-Process Technology
Sector and Competitors
1st jan.Capitalization (M$)
SAMSUNG BIOLOGICS CO.,LTD.-3.87%47 496
CSL LIMITED-3.03%96 409
BIOGEN INC.10.04%41 462
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.10.88%40 484
ALEXION PHARMACEUTICALS, INC.1.04%34 956
UCB3.67%20 143